Health Services Research
Latest posts by Health Services Research (see all)
- Effects of the Ten Percent Cap in Medicare Home Health Care on Treatment Intensity and Patient… - Mar. 02, 2015
- Acceptance of New Medicaid Patients by Primary Care Physicians and Experiences with Physician… - Feb. 13, 2015
- Regional Growth in Medicare Spending, 1992–2010 - Feb. 12, 2015
- Does Higher Spending Improve Survival Outcomes for Myocardial Infarction? Examining the… - Feb. 09, 2015
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: